Get it on Google Play

IMPAX Laboratories (IPXL) Receives FDA Approval for Generic Colestid

October 26, 2006 9:08 AM EDT Send to a Friend
IMPAX Laboratories, Inc. (OTC: IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login